Literature DB >> 17461039

[Quantification of metamorphopsia in the course of branch retinal vein occlusion with M-CHARTS].

Tomoya Nakagawa1, Seiyo Harino, Yoshiko Iwahashi.   

Abstract

PURPOSE: To evaluate visual function disorder in patients with branch retinal vein occlusion by quantifying the degree of metamorphopsia.
DESIGN: prospective interventional case series. SUBJECTS AND METHODS: The subjects were 12 patients(12 eyes) whose fovea was involved with branch retinal vein occlusion within a month after noticing their symptoms. The best-corrected visual acuity, and vertical and horizontal metamorphopsia scores were obtained within one month, and at 3 months and 6 months after the onset of symptoms regardless of therapy. The metamorphopsia scores were measured with M-CHARTS.
RESULTS: Although the average best-corrected visual acuity at 6 months was significantly better than that within a month of noticing symptoms, the average metamorphopsia scores did not improve after 6 months, and were not related to the average best-corrected visual acuity in either vertical or horizontal lines.
CONCLUSIONS: The degree of metamorphopsia measured with M-CHARTS is an important parameter in addition to the best-corrected visual acuity for evaluating visual function in patients with branch retinal vein occlusion.

Entities:  

Mesh:

Year:  2007        PMID: 17461039

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  7 in total

1.  Relationship between metamorphopsia and foveal microstructure in patients with branch retinal vein occlusion and cystoid macular edema.

Authors:  Tomoya Murakami; Fumiki Okamoto; Masaharu Iida; Yoshimi Sugiura; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-12       Impact factor: 3.117

2.  Metamorphopsia associated with central retinal vein occlusion.

Authors:  Koichiro Manabe; Rie Osaka; Yuki Nakano; Yukari Takasago; Tomoyoshi Fujita; Chieko Shiragami; Kazuyuki Hirooka; Yuki Muraoka; Akitaka Tsujikawa
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

3.  Persistent metamorphopsia associated with branch retinal vein occlusion.

Authors:  Rie Osaka; Koichiro Manabe; Saki Manabe; Yuki Nakano; Yukari Takasago; Chieko Shiragami; Kazuyuki Hirooka; Yuki Muraoka; Akitaka Tsujikawa
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

4.  Relationship between metamorphopsia and inner retinal microstructure following intravitreal ranibizumab injection for branch retinal vein occlusion.

Authors:  Yoshimi Sugiura; Fumiki Okamoto; Tomoya Murakami; Shohei Morikawa; Takahiro Hiraoka; Syed Amal Hussnain; Tetsuro Oshika
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

5.  M-charts as a tool for quantifying metamorphopsia in age-related macular degeneration treated with the bevacizumab injections.

Authors:  Katarzyna Nowomiejska; Agnieszka Oleszczuk; Agnieszka Brzozowska; Andrzej Grzybowski; Katarzyna Ksiazek; Ryszard Maciejewski; Piotr Ksiazek; Anselm Juenemann; Robert Rejdak
Journal:  BMC Ophthalmol       Date:  2013-04-15       Impact factor: 2.209

6.  Metamorphopsia Associated with Branch Retinal Vein Occlusion.

Authors:  Koichiro Manabe; Akitaka Tsujikawa; Rie Osaka; Yuki Nakano; Tomoyoshi Fujita; Chieko Shiragami; Kazuyuki Hirooka; Akihito Uji; Yuki Muraoka
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

7.  Metamorphopsia Score and Central Visual Field Outcomes in Diabetic Cystoid Macular Edema.

Authors:  Agnieszka Kalinowska; Katarzyna Nowomiejska; Agnieszka Brzozowska; Ryszard Maciejewski; Robert Rejdak
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.